Heterogeneity in the Effectiveness of Non-pharmaceutical Interventions During the First SARS-CoV2 Wave in the United States

被引:6
|
作者
Pan, William K. [1 ,2 ]
Fernandez, Daniel [3 ,4 ]
Tyrovolas, Stefanos [5 ,6 ,7 ]
Iago, Gine-Vazquez [6 ,7 ]
Dasgupta, Rishav Raj [2 ]
Zaitchik, Benjamin F. [8 ]
Lantos, Paul M. [2 ,9 ]
Woods, Christopher W. [2 ,9 ]
机构
[1] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA
[2] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA
[3] Polytech Universitat Politecn Catalunya Barcelona, Dept Stat & Operat Res, Barcelona, Spain
[4] Inst Math UPC BarcelonaTech IMTech, Barcelona, Spain
[5] Hong Kong Polytech Univ, WHO Collaborating Ctr Community Hlth Serv WHOCC, Sch Nursing, Hong Kong, Peoples R China
[6] Univ Barcelona, Parc Sanitari St Joan de Deu, Fundacio St Joan de Deu, Barcelona, Spain
[7] Ctr Invest Biomed Red Salud Mental CIBERSAM, Inst Salud Carlos III, Madrid, Spain
[8] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA
[9] Duke Univ, Duke Sch Med, Durham, NC USA
关键词
SARS-CoV-2; non-pharmaceutical intervention (NPI); doubling time; mortality rate; United States; AIRBORNE TRANSMISSION; COVID-19; OUTBREAKS; CORONAVIRUS;
D O I
10.3389/fpubh.2021.754696
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Attempts to quantify effect sizes of non-pharmaceutical interventions (NPI) to control COVID-19 in the US have not accounted for heterogeneity in social or environmental factors that may influence NPI effectiveness. This study quantifies national and sub-national effect sizes of NPIs during the early months of the pandemic in the US.Methods: Daily county-level COVID-19 cases and deaths during the first wave (January 2020 through phased removal of interventions) were obtained. County-level cases, doubling times, and death rates were compared to four increasingly restrictive NPI levels. Socio-demographic, climate and mobility factors were analyzed to explain and evaluate NPI heterogeneity, with mobility used to approximate NPI compliance. Analyses were conducted separately for the US and for each Census regions (Pacific, Mountain, east/West North Central, East/West South Central, South Atlantic, Middle Atlantic and New England). A stepped-wedge cluster-randomized trial analysis was used, leveraging the phased implementation of policies.Results: Aggressive (level 4) NPIs were associated with slower COVID-19 propagation, particularly in high compliance counties. Longer duration of level 4 NPIs was associated with lower case rates (log beta -0.028, 95% CI -0.04 to -0.02) and longer doubling times (log beta 0.02, 95% CI 0.01-0.03). Effects varied by Census region, for example, level 4 effects on doubling time in Pacific states were opposite to those in Middle Atlantic and New England states. NPI heterogeneity can be explained by differential timing of policy initiation and by variable socio-demographic county characteristics that predict compliance, particularly poverty and racial/ethnic population. Climate exhibits relatively consistent relationships across Census regions, for example, higher minimum temperature and specific humidity were associated with lower doubling times and higher death rates for this period of analysis in South Central, South Atlantic, Middle Atlantic, and New England states.Conclusion and Relevance: Heterogeneity exists in both the effectiveness of NPIs across US Census regions and policy compliance. This county-level variability indicates that control strategies are best designed at community-levels where policies can be tuned based on knowledge of local disparities and compliance with public health ordinances.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Transmission of SARS-CoV-2 in Indian states during lockdown: incorporating heterogeneity and non-pharmaceutical interventions
    Sindhwani, Rohit
    Saddikuti, Venkataramanaiah
    Vaidya, Omkarprasad S.
    INTERNATIONAL JOURNAL OF INDIAN CULTURE AND BUSINESS MANAGEMENT, 2021, 23 (04) : 490 - 521
  • [2] Estimating the effect of non-pharmaceutical interventions on US SARS-CoV-2 infections in the first year of the pandemic
    Duncan, N. A.
    L'Her, G. F.
    Osborne, A. G.
    Sawyer, S. L.
    Deinert, M. R.
    ROYAL SOCIETY OPEN SCIENCE, 2022, 9 (06):
  • [3] Impact of vaccination and non-pharmaceutical interventions on SARS-CoV-2 dynamics in Switzerland
    Shattock, Andrew J.
    Le Rutte, Epke A.
    Dunner, Robert P.
    Sen, Swapnoleena
    Kelly, Sherrie L.
    Chitnis, Nakul
    Penny, Melissa A.
    EPIDEMICS, 2022, 38
  • [4] Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland
    Joseph, Lemaitre C.
    Javier, Perez-Saez
    Andrew, Azman S.
    Andrea, Rinaldo
    Jacques, Fellay
    SWISS MEDICAL WEEKLY, 2020, 150
  • [5] Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions and testing
    Gurevich, Yael
    Ram, Yoav
    Hadany, Lilach
    EVOLUTION MEDICINE AND PUBLIC HEALTH, 2022, 10 (01) : 179 - 188
  • [6] Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States
    Yang, Bingyi
    Huang, Angkana T.
    Garcia-Carreras, Bernardo
    Hart, William E.
    Staid, Andrea
    Hitchings, Matt D. T.
    Lee, Elizabeth C.
    Howe, Chanelle J.
    Grantz, Kyra H.
    Wesolowksi, Amy
    Lemaitre, Joseph Chadi
    Rattigan, Susan
    Moreno, Carlos
    Borgert, Brooke A.
    Dale, Celeste
    Quigley, Nicole
    Cummings, Andrew
    McLorg, Alizee
    LoMonaco, Kaelene
    Schlossberg, Sarah
    Barron-Kraus, Drew
    Shrock, Harrison
    Lessler, Justin
    Laird, Carl D.
    Cummings, Derek A. T.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [7] The impact of non-pharmaceutical interventions on community non-SARS-CoV-2 respiratory infections in preschool children
    Klee, Bianca
    Diexer, Sophie
    Horn, Johannes
    Langer, Susan
    Wende, Marie
    Ortiz, Diego
    Bielecka, Agata
    Strowig, Till
    Mikolajczyk, Rafael
    Gottschick, Cornelia
    BMC PEDIATRICS, 2024, 24 (01)
  • [8] Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States
    Kim, Soyeoun
    Kim, Jinhyun
    Choi, Bo Youl
    Park, Boyoung
    EPIDEMIOLOGY AND HEALTH, 2022, 44
  • [9] Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy
    Giordano, Giulia
    Colaneri, Marta
    Di Filippo, Alessandro
    Blanchini, Franco
    Bolzern, Paolo
    De Nicolao, Giuseppe
    Sacchi, Paolo
    Colaneri, Patrizio
    Bruno, Raffaele
    NATURE MEDICINE, 2021, 27 (06) : 993 - +
  • [10] Non-pharmaceutical interventions and inoculation rate shape SARS-CoV-2 vaccination campaign success
    Galanti, Marta
    Pei, Sen
    Yamana, Teresa K.
    Angulo, Frederick J.
    Charos, Apostolos
    Khan, Farid
    Shea, Kimberly M.
    Swerdlow, David L.
    Shaman, Jeffrey
    EPIDEMIOLOGY AND INFECTION, 2021, 149